Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-03
DOI
10.1038/s41467-020-17148-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the frequency of non-motor symptoms of Parkinson’s disease in adult patients with Gaucher disease type 1
- (2019) Matheus V. M. B. Wilke et al. Orphanet Journal of Rare Diseases
- Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
- (2019) Mara Pavel-Dinu et al. Nature Communications
- GBA1-associated parkinsonism
- (2019) Emory Ryan et al. CURRENT OPINION IN NEUROLOGY
- Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
- (2019) Natalia Gomez-Ospina et al. Nature Communications
- Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis
- (2018) Megan E. Cahill et al. BMC INFECTIOUS DISEASES
- CRISPR/Cas9 genome editing in human hematopoietic stem cells
- (2018) Rasmus O Bak et al. Nature Protocols
- Gene Editing on Center Stage
- (2018) Rasmus O. Bak et al. TRENDS IN GENETICS
- Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease
- (2017) Manoj K. Pandey et al. NATURE
- Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
- (2017) Rasmus O Bak et al. eLife
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- CCR5 deficiency predisposes to fatal outcome in influenza virus infection
- (2015) A. Falcon et al. JOURNAL OF GENERAL VIROLOGY
- Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice
- (2015) Maria Dahl et al. MOLECULAR THERAPY
- Gene therapy returns to centre stage
- (2015) Luigi Naldini NATURE
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
- (2015) Ayal Hendel et al. NATURE BIOTECHNOLOGY
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses
- (2013) Maria J. Ferraz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model
- (2013) Manoj Kumar Pandey et al. MOLECULAR GENETICS AND METABOLISM
- Lentiviral vector–based insertional mutagenesis identifies genes associated with liver cancer
- (2013) Marco Ranzani et al. NATURE METHODS
- Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease
- (2013) Maciej Machaczka PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Gauchers Disease—A Reappraisal of Hematopoietic Stem Cell Transplantation
- (2013) Sawa Ito et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment
- (2012) Neal J. Weinreb et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2R null humanized mice
- (2011) E. Billerbeck et al. BLOOD
- Evaluation of macrophage-specific promoters using lentiviral delivery in mice
- (2011) M C Levin et al. GENE THERAPY
- Long-term Adaptive Functioning Outcomes of Children With Inherited Metabolic and Genetic Diseases Treated With Hematopoietic Stem Cell Transplantation in a Single Large Pediatric Center
- (2011) Adam Gassas et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Site-specific integration and tailoring of cassette design for sustainable gene transfer
- (2011) Angelo Lombardo et al. NATURE METHODS
- AAV-mediated gene targeting methods for human cells
- (2011) Iram F Khan et al. Nature Protocols
- The galactocerebrosidase enzyme contributes to the maintenance of a functional hematopoietic stem cell niche
- (2010) I. Visigalli et al. BLOOD
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Comparison of human cord blood engraftment between immunocompromised mouse strains
- (2010) S. P. McDermott et al. BLOOD
- AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
- (2010) M Wunderlich et al. LEUKEMIA
- The generation and properties of human macrophage populations from hemopoietic stem cells
- (2009) Kerrie J. Way et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful Low-Risk Hematopoietic Cell Therapy in a Mouse Model of Type 1 Gaucher Disease
- (2008) Ida Berglin Enquist et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation